IPA Company Profile and Key Details
ImmunoPrecise Antibodies Ltd.
IPA Stock Price Chart
Stock Price Today
ImmunoPrecise Antibodies Ltd. (IPA) stock surged +30.73%, trading at $0.64 on NASDAQ, up from the previous close of $0.49. The stock opened at $0.72, fluctuating between $0.61 and $0.92 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.
Company Information
| Employees | 72 |
| Beta | 0.27 |
| Sales or Revenue | $24.52M |
| 5Y Sales Change% | 0.098% |
| Fiscal Year Ends | April |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) stock price is $0.64 in the last trading session. During the trading session, IPA stock reached the peak price of $0.92 while $0.61 was the lowest point it dropped to. The percentage change in IPA stock occurred in the recent session was 30.73% while the dollar amount for the price change in IPA stock was $0.15.
The NASDAQ listed IPA is part of Biotechnology industry that operates in the broader Healthcare sector. ImmunoPrecise Antibodies Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Ilse Roodink
Chief Scientific Officer
Dr. Roland Romijn
Head of Gen. Operations of the Utrecht site of IPA (Europe)
Dr. Jennifer Lynne Bath Ph.D.
Chief Executive Officer, Pres & Non-Independent Director
Mr. David E. Orton
Chief Operating Officer
Mr. Brad McConn
Chief Financial Officer
Ms. Carla Dahl
Vice President of Marketing
Dr. Barry Neil Duplantis
Vice President of Client Relations
IPA's closing price is 98.31% higher than its 52-week low of $0.33 where as its distance from 52-week high of $2.60 is -75.21%.
Number of IPA employees currently stands at 72.
Official Website of IPA is: https://www.ipatherapeutics.com
IPA could be contacted at phone 250 483 0308 and can also be accessed through its website. IPA operates from 3204–4464 Markham Street, Victoria, BC V8Z 7X8, Canada.
IPA stock volume for the day was 326.37M shares. The average number of IPA shares traded daily for last 3 months was 628.58K.
The market value of IPA currently stands at $19.96M with its latest stock price at $0.64 and 30.97M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com